Management of severe infusion reactions after cetuximab

By Cerman Jaroslav   Melichar Bohuslav   Cermanova Melanie   Solichova Dagmar  

Acta Oncologica, Vol. 47, Iss. 8, 2008-01 ,pp. : 1609-1611

Informa Healthcare

Access to resources Recommend Favorite

A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management

By Jang Jeong   Bae Si   Choi Jong   Oh Hyun   Kim Min   Lee So   Kim Chang   Chang U   Nam Soon   Cha Sang   Lee Young   Chun Ho   Choi Byung   Byun Jae   Yoon Seung  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 9-15

Springer Publishing Company

Access to resources Recommend Favorite

Retrospective chart review of severe infusion reactions with rituximab, cetuximab, and bevacizumab in community oncology practices: assessment of clinical consequences

By Schwartzberg Lee  

Supportive Care in Cancer, Vol. 16, Iss. 4, 2008-04 ,pp. : 393-398

Springer Publishing Company

Access to resources Recommend Favorite

Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab

By                    

Oncology Reports, Vol. 28, Iss. 1, 2012-01 ,pp. : 49-54

Spandidos Publications

Access to resources Recommend Favorite

Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear

By Windsor Alastair CJ   Cohen Richard   Jiao Long R   Stebbing Justin  

Future Oncology, Vol. 4, Iss. 6, 2008-12 ,pp. : 741-744

Future Medicine

Access to resources Recommend Favorite